Holen Sie sich die Stockscreener-App
5.58
0.89%
-0.05
Vorhandelsmarkt:
5.59
0.010
+0.18%
Schlusskurs vom Vortag:
$5.63
Offen:
$5.62
24-Stunden-Volumen:
162.41K
Relative Volume:
0.53
Marktkapitalisierung:
$148.07M
Einnahmen:
$56.65M
Nettoeinkommen (Verlust:
$-53.31M
KGV:
-2.7297
EPS:
-2.0442
Netto-Cashflow:
$-40.75M
1W Leistung:
-8.67%
1M Leistung:
-18.78%
6M Leistung:
-43.12%
1J Leistung:
-17.94%
1-Tages-Spanne:
$5.52
$5.7699
1-Wochen-Bereich:
$5.49
$6.23
52-Wochen-Spanne:
$4.3701
$11.30
Cvrx Inc Stock (CVRX) Company Profile
Firmenname
Cvrx Inc
Sektor
Branche
Telefon
(763) 416-2850
Adresse
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
Compare CVRX vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVRX
Cvrx Inc
|
5.58 | 149.40M | 56.65M | -53.31M | -40.75M | -2.0442 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Cvrx Inc Stock (CVRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-01-14 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-09-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-07-11 | Bestätigt | Lake Street | Buy |
| 2024-05-01 | Fortgesetzt | Craig Hallum | Buy |
| 2024-05-01 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-05-01 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-01-31 | Eingeleitet | Lake Street | Buy |
| 2022-07-18 | Eingeleitet | Craig Hallum | Buy |
| 2021-07-26 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-26 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-26 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Cvrx Inc Aktie (CVRX) Neueste Nachrichten
CVRx stock up on Humana's Medicare coverage for Barostim therapy - MSN
CVRx to present at Goldman Sachs Healthcare Con... | Pluang – Crypto, Stocks, Gold & Funds - Pluang
CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference - GlobeNewswire
CVRX News | CVRX INC (NASDAQ:CVRX) - ChartMill
Understanding Momentum Shifts in (CVRX) - Stock Traders Daily
CVRx, Inc.Common Stock (NQ: CVRX - The Chronicle-Journal
Clinical research teams accelerate progress in treatment options, CVRx asserts - Traders Union
CVRx to Present at the William Blair 46th Annual Growth Stock Conference - 富途牛牛
What Humana (HUM)'s Expanded Barostim Coverage Means For Shareholders - simplywall.st
CVRx to present at William Blair Growth Stock Conference on June 2, 2026 - Pluang
CVRx marks 25th Barostim implant milestone at UNC Medical Center Chapel Hill - Traders Union
CVRx Stock Up on Humana's Medicare Coverage for Barostim Therapy - Yahoo Finance
CVRx rebounds as Humana issues Medicare policy for Barostim - MSN
CVRx Inc stock (US12674F1003): Medtronic takeover bid puts heart-device specialist in the spotlight - AD HOC NEWS
Number of shareholders of CVRx, Inc. – NASDAQ:CVRX - TradingView
CVRx Gains Momentum With Revenue Growth, BENEFIT-HF Progress and Humana Coverage Win - TipRanks
CVRx (CVRX) reports Q1 loss, beats revenue estimates - MSN
The CVRx, Inc. (NASDAQ:CVRX) First-Quarter Results Are Out And Analysts Have Published New Forecasts - simplywall.st
Analysts Have Made A Financial Statement On CVRx, Inc.'s (NASDAQ:CVRX) First-Quarter Report - Yahoo Finance
CVRx Announces Humana Medicare Advantage Coverage Policy for Barostim Therapy - Sahm
Humana (HUM) Expands Medicare Advantage Coverage for Barostim Th - GuruFocus
CVRx earns Humana Medicare Advantage win for Barostim - MassDevice
CVRx stock gains as Humana to cover Barostim - Seeking Alpha
Humana issues Medicare Advantage coverage for CVRx Barostim therapy By Investing.com - Investing.com Nigeria
Humana issues Medicare Advantage coverage for CVRx Barostim therapy - Investing.com
Humana expands Barostim therapy access via Medicare Advantage, CVRx secures national deal - Traders Union
CVRx announces Humana Medicare Advantage coverage policy for Barostim therapy - marketscreener.com
Humana adds Medicare Advantage coverage for CVRx heart-failure implant - Stock Titan
Lake Street Maintains CVRx Inc(CVRX.US) With Buy Rating, Maintains Target Price $14 - Moomoo
CVRx Inc | 10-Q: Q1 2026 Earnings Report - Moomoo
Down 31.7% in 4 Weeks, Here's Why You Should You Buy the Dip in CVRx (CVRX) - Yahoo Finance
TradingKey - TradingKey
CVRx Earnings Call Highlights Growth Amid Ongoing Losses - The Globe and Mail
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
CVRx stock (US12674F1003): Q1 revenue jumps 20% to $14.8M - AD HOC NEWS
Lake Street Initiates CVRx Inc(CVRX.US) With Buy Rating, Announces Target Price $14 - Moomoo
J.P. Morgan Maintains CVRx Inc(CVRX.US) With Sell Rating, Maintains Target Price $6 - Moomoo
A Quick Look at Today's Ratings for CVRx Inc(CVRX.US), With a Forecast Between $6 to $12 - Moomoo
CVRx, Inc. (NASDAQ:CVRX) Q1 2026 Earnings Call Transcript - Insider Monkey
CVRx revenue up 20% to USD 14.8M in Q1 2026 - Medical Buyer
CVRx, Inc. 1Q 2026: Revenue $14.77M, EPS ($0.5) — 10-Q Summary - TradingView
CVRx (NASDAQ: CVRX) grows Q1 revenue 20% as net loss narrows - Stock Titan
Avoiding Lag: Real-Time Signals in (CVRX) Movement - Stock Traders Daily
CVRx earnings beat by $0.02, revenue topped estimates By Investing.com - Investing.com South Africa
CVRx Q1 Earnings Call Highlights - sharewise.com
Earnings call transcript: CVRx beats Q1 2026 forecasts, stock rises - Investing.com India
CVRx revenue rises 20 percent in first quarter as U.S. operations expand - Traders Union
Finanzdaten der Cvrx Inc-Aktie (CVRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
1.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):